Blog

Changes to Plaquenil risk calculator

I've made a few changes to the plaquenil risk calculator. A few of the changes were in the interest of user-friendliness, but the more important changes are as follows.

plaquenil

I removed the chloroquine calculations. I can't recall the last time I saw a patient taking this (as opposed to hydroxychloroquine) and I feel presenting it as an option was only a potential source of confusion or errors.

I included some sliders for adjusting height and weight for BMI calculations. On the surface this may seem cosmetic but it also allows for our metric system users (which I call the "smart ones") to enter these values in kilograms and meters instead of ponds and feet/inches.

I made the cumulative Plaquenil dose calculator a bit more robust. It originally only accepted a dose and a duration in months and years. However, I realized that 1) Sometimes dosages change and 2) sometimes doses are irregular.

For example, if a person takes 400mg bid x 1 year, then changes to 200mg qd x 1 year, you can now add rows to the calculator by pressing the "+" button. You can do this as many times as you like.

plaquenil cumulative add row

In addition, I realized that I was seeing a lot of patients that were taking dosages like this: 400mg every other day, with 200mg on the opposite days. I added a "qod" sig option that can cover these more difficult prescribing patterns.

plaquenil cumulative qod

Hopefully that'll cover the majority of our needs for these calculations. If you run into any other commonplace scenarios that I haven't covered please let me know.

 

Sauflon launch clariti® to the United States market

SAUFLON ANNOUNCES INTRODUCTION OF WORLD’S FIRST AND ONLY FAMILY OF SILICONE HYDROGEL DAILY DISPOSABLE CONTACT LENSES TO THE UNITED STATES MARKET.clariti-1day-family1

– World’s Fastest Growing Contact Lens Company to Introduce clariti® 1 day, the First Family of Sphere, Toric and Multifocal Silicone Hydrogel Daily Disposable Contact Lenses

NEW YORK, Jan. 13, 2014 — Sauflon, the world’s fastest growing contact lens company, today announced that it is entering the U.S. contact lens market with its award-winning clariti 1 day silicone hydrogel daily disposable contact lenses. As the world’s first and only family of sphere, toric and multifocal silicone hydrogel daily disposable contact lenses, clariti 1 day is able to satisfy the broad range of practitioner and patient needs. Sauflon’s breakthrough AquaGen™ technology produces high quality silicone hydrogel lenses that provide exceptional comfort and affordable convenience for the wearer.

Read more: Sauflon launch clariti® to the United States market

CLs & EMRs: A better way

 I’ve spent the last decade writing contact lens calculators, cataloguing contact lenses, and writing code to search and display contact lens information. After all the nights and weekends hunched in front of my computer, and despite the fact that I’m proud of what I’ve created, you might be surprised to hear what I say next: I wish there was less need for EyeDock. Yup, you heard me. I feel that a site like EyeDock should be a little superfluous.


I’ve felt this way since our clinic switched to an EMR 5 years ago. Mind you, I’m not using one of the cool optometry-specific EMRs that a lot of you are using. My EMR is Epic, which does cardiology, oncology, pretty much everything else, and eye care. I actually think it’s good for what it is, but it’s not tailor-made for ODs.

 

Read more: CLs & EMRs: A better way

CooperVision Launches Biofinity® XR Contact Lenses

[press release]

Cooper logo


Pleasanton, CA, October 21, 2013— CooperVision, Inc. today announced the launch of its Biofinity® XR contact lens brand. This is

an extension to its popular Biofinity (comfilcon A) silicone hydrogel technology, allowing practitioners to confidently fit a greater number of monthly replacement lens patients, including those with significant hyperopia and myopia.  


Every day, countless people who suffer from severe near- and far-sightedness are faced with less than optimal choices to correct their vision. Thick glasses can create distortion and upend fashion sensibilities. Older contact lens materials limit “breathability,” with less oxygen reaching the eye. And the latest high performance lenses have only covered a limited range of prescriptions. 


The Biofinity XR lens is the first of its kind that combines high oxygen permeability with all-day comfort characteristics required for wearers with more demanding prescriptions. With Biofinity XR, more people can enjoy the benefits of modern contact lens material and design, helping them live life without the hassle of glasses. 


“The availability of Biofinity XR gives eye care practitioners another reason to make it a monthly lens of choice, whether transitioning Proclear® wearers, upgrading from a competitive lens, or introducing a broader span of spectacle wearers to soft lenses,” said Dr. Juan Carlos Aragon, senior vice president, Global Professional & Clinical Affairs, CooperVision. “The same outstanding vision, fit and comfort properties that the eye care community has come to expect from Biofinity are now available with Biofinity XR lenses.”


Biofinity XR is the only extended range monthly contact lens brand with Aquaform® Technology. This technology makes the lens material highly breathable so more oxygen reaches the eyes, helping keep them clearer and whiter with less irritation. It also ensures that the lenses are naturally and uniformly wettable for smoothness and comfort, and maintains softness and flexibility for more gentle wear from the first day to the last.


Biofinity XR lenses are now available in powers from +8.50 to +15.00 (0.50 steps) and -12.50 to -20.00 (0.50 steps). The current Biofinity line continues to be available in +8.00 to -12.00 powers.

Subcategories